Nikhil Munshi
MD
Professor of Medicine
👥Biography 个人简介
Nikhil Munshi led the landmark KarMMa clinical trial establishing idecabtagene vicleucel (ide-cel) as the first CAR-T cell therapy approved for multiple myeloma. His research has focused on BCMA-targeted immunotherapies and the genomic landscape of myeloma to identify new therapeutic targets. He has contributed extensively to understanding myeloma tumor biology and mechanisms of drug resistance. His clinical research has established new standards of care for relapsed/refractory myeloma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Nikhil Munshi 的研究动态
Follow Nikhil Munshi's research updates
留下邮箱，当我们发布与 Nikhil Munshi（Dana-Farber Cancer Institute, VA Boston Healthcare System）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment